SRZN
SRZN
NASDAQ · Biotechnology

Surrozen Inc

$28.90
+0.90 (+3.21%)
As of Mar 29, 10:35 PM ET ·
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Buy 8 89%
Hold 1 11%
Sell 0 0%
Price Target
Analyst Price Target -72.5% upside
Low Target $5.53
Average Target $7.94
High Target $9.87
Current Price $28.90
Current
$28.90
Target
$7.94
$5.53 $7.94 avg $9.87
Scenario Analysis
Bear Case
$5.53
-80.9%
Low target
Base Case
$7.94
-72.5%
Avg target
Bull Case
$9.87
+-65.8%
High target
Risk/Reward
0.8x
Unfavorable
Price in Context
52-Week High
$29.60
-2.3% from high
52-Week Low
$5.90
+389.8% from low
Target vs 52W High
$7.94
-73.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +19.8%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.0%
GILD
Gilead Sciences Inc
Strong Buy 38 79% $362.68 +158.5%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -2.0%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -13.0%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -29.7%